76. 依據 2018 AASLD Guidelines for the Treatment of Hepatocellular Carcinoma,下列何者敘述正確?
(1) The AASLD suggests surveillance using ultrasound (US) with or without
alpha-fetoprotein (AFP) every 6 months.
(2) The AASLD suggests observation with follow-up imaging over treatment for patients with cirrhosis awaiting liver transplantation who develop T1 HCC.
(3) The AASLD suggests that adults with Child-Pugh class A cirrhosis and resectable T1 or T2 HCC undergo resection over radiofrequency ablation.
(4) The AASLD suggests bridging to transplant in patients listed for liver transplantation within OPTN T2 (Milan) criteria to decrease progression of disease and subsequent dropout from the waiting list.
(A) (2)+(3)+(4)
(B) (3)+(4)
(C) (3)
(D) (1)+(2)
(E) (1)+(2)+(3)+(4)
統計: A(0), B(1), C(0), D(0), E(3) #3587271